Friday, June 25, 2021 4:28:18 PM
If we get no news next week, I think we could see those levels, but I think we get some good news by Wednesday, since they haven't had a month this year with only one PR. It could still drop to that .11-13 with news, we have had it happen before where we get news and the price continued to drop.
However, I think our timeline is now further along with Covid and Cancer drug testing that the range of share price fluctuations are tightening up as share holders are anticipating that we are getting closer to news that can send us to new highs.
But that's just my opinion and speculation. There was a tweet from Rosen about getting mice results from covid testing around mid to end of June and applying for FDA approval/fast track. Lately he hasn't been far off on timeframes for pending developments. I'm hopeful we get news on Monday, Tuesday or Wednesday about covid mice results or possibly adva-27a testing. But who knows...
However, I think our timeline is now further along with Covid and Cancer drug testing that the range of share price fluctuations are tightening up as share holders are anticipating that we are getting closer to news that can send us to new highs.
But that's just my opinion and speculation. There was a tweet from Rosen about getting mice results from covid testing around mid to end of June and applying for FDA approval/fast track. Lately he hasn't been far off on timeframes for pending developments. I'm hopeful we get news on Monday, Tuesday or Wednesday about covid mice results or possibly adva-27a testing. But who knows...
Recent SBFM News
- Sunshine Biopharma Reports Fiscal 2025 Revenue of $36.3 Million, a 4.1% Increase Over Prior Year • ACCESS Newswire • 04/06/2026 12:30:00 PM
- Sunshine Biopharma Gains FDA-Equivalent Clearance in Canada for Domperidone to Treat Cancer-related Nausea • ACCESS Newswire • 10/28/2025 11:45:00 AM
- Sunshine Biopharma Launches STD, Acne and Lyme Disease Therapy Doxycycline • ACCESS Newswire • 10/20/2025 11:45:00 AM
- Sunshine Biopharma Launches Cholesterol Fighting Medicine Pravastatin • ACCESS Newswire • 10/16/2025 11:45:00 AM
- Sunshine Biopharma Allocates $5 Million for Investment in Bitcoin as Strategic Reserve Asset to Enhance Treasury Resilience • ACCESS Newswire • 10/14/2025 11:00:00 AM
- Sunshine Biopharma and University of Arizona Develop a Potent New Series of Protease Inhibitors for Treatment of SARS Coronavirus Infections • ACCESS Newswire • 10/09/2025 12:00:00 PM
